天佑德酒(002646.SZ):子公司西藏阿拉嘉寶收到政府補助835.35萬元
格隆匯4月11日丨天佑德酒(002646.SZ)公佈,公司全資子公司西藏阿拉嘉寶酒業有限責任公司(以下簡稱"西藏阿拉嘉寶")於2024年4月9日收到西藏拉薩經濟技術開發區管理委員會2023年產業扶持資金8,353,530.00元,補助形式為現金,為與收益相關的政府補助。佔公司最近一期經審計歸屬於上市公司股東的淨利潤的比例為11.10%,該項補助與公司日常經營活動相關,西藏阿拉嘉寶已經實際收到相關款項,具有可持續性。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.